Symptoms Six Weeks After COVID-19 Are Reduced Among US Health Care Personnel Receiving Additional Vaccine Doses During the Omicron Period, December 2021-April 2022
Nicholas M Mohr,Ian D Plumb,Eliezer Santos León,Malea Pinckney,Karisa K Harland,Anusha Krishnadasan,Karin F Hoth,Fernand Rwamwejo,John P Haran,Melissa Briggs-Hagen,Eric Kontowicz,David A Talan,Project PREVENT Network,Sydney Krispin,Allison Schuette,Jillian Tozloski,Lili O'Brian,Laura McCormick,Karen Hopcia,Theresa M Orechia,Alexander B Hill,Gabrielle Donohoe,Lily R Johnsky,Jordyn M Fofi,Steven E Miyawaki,Jenson J Kaithamattam,Michelle Chung,Nikita A Umale,Mohammad Adrian Hasdianda,Guruprasad Jambaulikar,Tala Teymour,Maria Davila,Suzette Fernandez,Elizabeth Krebs,Joshua Tiao,Stacey Wisniewski,Gaynell Bernadas-Hunt,Alexander Vandeerlin,Domnic Bett,Cathryn Leggio,Alexandria Henderson,Reynaldo Padilla,Cynthia Delgado,Madeleine Manahan,Susana Hacopian,Vincent E Yu,Melanie Potts,Jessica Kuo,Alyssa Fowlds,Lidia Choxom,Amy Dakos,Denise Tritt,Zoe Speight,Laurie Kemble,Danielle Beckham,Cecile Hermanns,Geneatra Green,Rachel Marrs,Katherine Schneider,Catherine Fairfield,Shannon Landers,Eliezer Santos,Nathan R Kramer,Fred Ullrich,Virginia Mangolds,Morgan Nelson,Abigail Lopes,James Galbraith,Lucia Solis,Rebekah Peacock,Alan Jones,Bhagyashri Navalkele,Savannah Vann,Alexander Kile,Joel Rodgers,Nivedita Patkar,Delissa Tidwell-Hand,Whitney Covington,Michael C Kurz,Peter Poerzgen,Megan Fuentes,Layla A Anderson,Kyle A Steinbock,Alison Zelikoff,John B Lynch,Jennifer Smith,Glen R Abedi,Sankan Nyanseor,Christopher K Watts,Jade James Gist,Sharon Saydah,Matthew McCullough,Howard A Smithline,Peter C Hou,Lilly C Lee,Stephen C Lim,Gregory J Moran,Mark T Steele,David G Beiser,Brett Faine,Utsav Nandi,Walter A Schrading,Brian Chinnock,Anne Chipman,Christine D Crider,Frank LoVecchio,Alysia Horcher,Kelli Wallace,Lisandra Uribe,Kavitha Pathmarajah,Abigail L Girardin,Dean M Hashimoto,Monica Bahamon,Michelle St Romain,Efrat Kean,Zachary Mankoff,Amy Stubbs,Sara Roy,Gregory Volturo,Amanda Higgins,James C Crosby,Mary Mulrow,Eva Gonzalez,J Priyanka Vakkalanka
DOI: https://doi.org/10.1093/ofid/ofae545
2024-09-25
Abstract:Background: The objective of this study was to test the hypothesis that subsequent doses of the coronavirus disease 2019 (COVID-19) vaccine are associated with lower incidence of COVID-19-like symptoms at 6 weeks after infection. Methods: This study was a case-control analysis of health care personnel in an ongoing multicenter COVID-19 vaccine effectiveness study. We enrolled participants at the time of COVID-19-like symptoms between December 19, 2021, and April 27, 2022, which corresponded to the early Omicron-predominant period after original monovalent severe acute respiratory syndrome coronavirus 2 additional vaccination doses became available. Our outcome was self-reported symptoms completed 6 weeks after the onset of symptoms. Results: We enrolled 2478 participants, of whom 1422 (57%) had COVID-19. The prevalence of symptoms at 6 weeks was 26% (n = 373) in those with COVID-19 and 18% (n = 195) in those without COVID-19. Fatigue (11%) and difficulty sleeping (7%) were most strongly associated with COVID-19. A total of 1643 (66%) participants received a subsequent vaccine dose (after the primary series). Participants with COVID-19 who had received a subsequent vaccination had lower odds of symptoms at 6 weeks (adjusted odds ratio [aOR], 0.55; 95% CI, 0.43-0.70), but this relationship was not observed in those without COVID-19 (aOR, 0.87; 95% CI, 0.59-1.29). Conclusions: Health care personnel who received subsequent doses of original monovalent COVID-19 vaccine had a lower prevalence of symptoms at 6 weeks than those that did not.